Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NOVN

Novan (NOVN) Stock Price, News & Analysis

Novan logo

About Novan Stock (NASDAQ:NOVN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
7.19 million shs
Average Volume
602,421 shs
Market Capitalization
$2.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NOVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter.

NOVN Stock News Headlines

Novartis AG
Novartis AG Registered Shares
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Novartis AG Registered Shares NOVN
Novan reaches deals to sell assets in bankruptcy case
Firm Retention Summary: Novan
See More Headlines

NOVN Stock Analysis - Frequently Asked Questions

Novan, Inc. (NASDAQ:NOVN) announced its earnings results on Monday, May, 15th. The company reported ($0.54) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.22. The business had revenue of $3.17 million for the quarter, compared to analyst estimates of $6.19 million. Novan had a negative trailing twelve-month return on equity of 700.28% and a negative net margin of 128.61%.
Read the conference call transcript
.

Novan (NOVN) raised $46 million in an initial public offering (IPO) on Wednesday, September 21st 2016. The company issued 3,800,000 shares at a price of $11.00-$13.00 per share. Piper Jaffray acted as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novan investors own include Meta Platforms (META), Bionano Genomics (BNGO), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), NIO (NIO), Tesla (TSLA) and Zomedica (ZOM).

Company Calendar

Last Earnings
5/15/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NOVN
CIK
1467154
Employees
90
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.31 million
Net Margins
-128.61%
Pretax Margin
-128.39%
Return on Equity
-700.28%
Return on Assets
-39.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.74
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$24.71 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,015,000
Free Float
27,651,000
Market Cap
$2.64 million
Optionable
Not Optionable
Beta
-0.06

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:NOVN) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners